United States · FDA National Drug Code directory
BUPRENORPHINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58118-0502_0e859e75-928c-e576-e063-6294a90a8421
- Product NDC
- 58118-0502
- Form
- TABLET
- Composition / generic term
- BUPRENORPHINE
- Labeler
- Clinical Solutions Wholesale, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171025
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BLISTER PACK (58118-0502-8) · 58118-0502-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →